Follow
Tomás A. Martins
Tomás A. Martins
PhD student, University of Basel
Verified email at unibas.ch
Title
Cited by
Cited by
Year
Co-evolution of matrisome and adaptive adhesion dynamics drives ovarian cancer chemoresistance
EA Pietilä, J Gonzalez-Molina, L Moyano-Galceran, S Jamalzadeh, ...
Nature communications 12 (1), 3904, 2021
842021
Severe Neuro-COVID is associated with peripheral immune signatures, autoimmunity and neurodegeneration: a prospective cross-sectional study
MM Etter, TA Martins, L Kulsvehagen, E Pössnecker, W Duchemin, ...
Nature communications 13 (1), 6777, 2022
392022
Immunotherapy of glioblastoma explants induces interferon-γ responses and spatial immune cell rearrangements in tumor center, but not periphery
T Shekarian, CP Zinner, EM Bartoszek, W Duchemin, AT Wachnowicz, ...
Science Advances 8 (26), eabn9440, 2022
232022
Microglia-centered combinatorial strategies against glioblastoma
TA Martins, P Schmassmann, T Shekarian, JL Boulay, MF Ritz, ...
Frontiers in immunology 11, 571951, 2020
182020
Targeting the Siglec–Sialic acid axis promotes antitumor immune responses in preclinical models of glioblastoma
P Schmassmann, J Roux, A Buck, N Tatari, S Hogan, J Wang, ...
Science translational medicine 15 (705), eadf5302, 2023
72023
Severe Neuro-COVID is associated with peripheral immune signatures, autoimmunity and signs of neurodegeneration: A prospective cross-sectional study
MM Etter, T A. Martins, L Kulsvehagen, E Pössnecker, W Duchemin, ...
medRxiv, 2022.02. 18.22271039, 2022
32022
Single-cell characterization of human GBM reveals regional differences in tumor-infiltrating leukocyte activation
P Schmassmann, J Roux, S Dettling, S Hogan, T Shekarian, TA Martins, ...
Elife 12, RP92678, 2023
22023
ENHANCING GLIOBLASTOMA CLEARANCE: EMPOWERING ANTI-EGFRVIII CAR T CELLS WITH A PARACRINE SIRPGamma-DERIVED CD47 BLOCKER
T Martins, N Tatari, D Kaymak, EM Bartoszek, S Hogan, A Buck, MF Ritz, ...
NEURO-ONCOLOGY 25, 2023
2023
Enhancing anti-EGFRvIII CAR T cell therapy against glioblastoma with a paracrine SIRPγ-derived CD47 blocker
TA Martins, N Tatari, D Kaymak, S Hogan, EM Bartoszek, R Wieboldt, ...
bioRxiv, 2023.08. 31.555122, 2023
2023
Multidimensional analysis of matched primary and recurrent glioblastoma identifies Fcgamma receptors upregulation on microglia as a contributor of tumor recurrence.
T Shekarian, S Hogan, TA Martins, P Schmassmann, A Gerber, J Roux, ...
bioRxiv, 2023.04. 21.537308, 2023
2023
Angiopoietin 1 and integrin beta 1b are vital for zebrafish brain development
YC Chen, TA Martins, V Marchica, P Panula
Frontiers in Cellular Neuroscience 17, 2023
2023
The Siglec-sialic acid-axis is a target for innate immunotherapy of glioblastoma
P Schmassmann, J Roux, A Buck, N Tatari, S Hogan, J Wang, S Lee, ...
bioRxiv, 2022.11. 07.515406, 2022
2022
TMIC-77. SINGLE-CELL CHARACTERIZATION OF HUMAN GBM REVEALS REGIONAL DIFFERENCES IN TUMOR-INFILTRATING LEUKOCYTE ACTIVATION
P Schmassmann, J Roux, S Dettling, S Hogan, T Shekarian, TA Martins, ...
Neuro-Oncology 24 (Suppl 7), vii288, 2022
2022
HUMANIN RELEASE FROM TUMOR ASSOCIATED MYELOID CELLS PROMOTES GLIOMA CHEMORESISTANCE
P Schmassmann, J Roux, S Dettling, S Hogan, T Shekarian, TA Martins, ...
NEURO-ONCOLOGY 24, 288-288, 2022
2022
P06. 03. A Combination of EGFRvIII CAR T cell therapy and paracrine GAM modulation for the treatment of GBM
TA Martins, N Tatari, M Ritz, T Shekarian, P Schmassmann, D Kaymak, ...
Neuro-Oncology 24 (Suppl 2), ii38, 2022
2022
P17. 10. B Identification of mechanisms involved in the recurrence of glioblastoma by transcriptomic, proteomic and spatial profiling analysis
M Ritz, T Shekarian, T Martins, S Hogan, P Schmassmann, B Burger, ...
Neuro-Oncology 24 (Suppl 2), ii91, 2022
2022
IMMU-40. IMMUNE PROFILING OF MATCHED PRIMARY AND RECURRENT GLIOBLASTOMA TUMORS IDENTIFIED CD64 AS A NEGATIVE PREDICTOR FOR SURVIVAL
T Shekarian, MF Ritz, T Martins, P Schmassmann, G Hutter
Neuro-Oncology 23 (Supplement_6), vi101-vi101, 2021
2021
COMBINATION OF EGFRVIII CAR T-CELL THERAPY AND PARACRINE GAM MODULATION FOR THE TREATMENT OF GBM
TA Martins, MF Ritz, T Shekarian, P Schmassmann, D Kaymak, V Bicvic, ...
NEURO-ONCOLOGY 23, 102-103, 2021
2021
THE IMPACT OF MICROGLIA MODULATION ON GBM PROGRESSION IN SYNGENEIC MOUSE MODELS
MF Ritz, T Shekarian, TA Martins, P Schmassmann, G Hutter
NEURO-ONCOLOGY 23, 96-96, 2021
2021
EXTH-45. MICROGLIA-SPECIFIC DISRUPTION OF SIALIC ACID-SIGLEC-9/E INTERACTIONS: A NOVEL IMMUNOTHERAPY AGAINST GLIOBLASTOMA?
P Schmassmann, TA Martins, M Stanczak, MF Ritz, T Shekarian, ...
Neuro-Oncology 23 (Suppl 6), vi173, 2021
2021
The system can't perform the operation now. Try again later.
Articles 1–20